Interesting, I didn’t catch that on my first read and haven’t looked at the clinical trial to see if it has a 1b arm or what protocol is outlined.
It does seem odd not to have the CTC included as that should provide support for accelerated approval as a surrogate endpoint. You may be correct in this is somehow linked to RP. Glad we have another Phase 2 and waiting to see how everything plays out.
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.